Liu Gang, Chen Xiang-Ting, Zhang Hao, Chen Xin
Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Department of Neurology, Bishan Hospital of Chongqing Medical University, Chongqing, China.
Front Oncol. 2022 Dec 1;12:1019247. doi: 10.3389/fonc.2022.1019247. eCollection 2022.
To investigate the relationship between changes in peripheral blood vascular endothelial growth factor (VEGF), interleukin-5 (IL-5), interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-17 (IL-17) concentrations in breast cancer patients and their significance and clinical value in breast cancer staging and invasive metastasis.
From September 2021 to April 2022, 60 breast cancer patients from Chongqing Medical University Hospital No. 2022 were enrolled in the breast breast cancer surgery group, while 30 patients with benign breast disease were enrolled in the control group during the same period. Venous blood samples were collected at admission and 1 week after surgery to determine the expression of these factors in serum. Statistical methods such as Wilcoxon test and Spearman correlation analysis were used to analyze the relationship between the above factors and the clinicopathological characteristics of the patients.
By analyzing data from patients with benign and malignant breast tumors, an association was found with serum levels of IL-6, IL-17 and VEGF. Their respective areas under the operating characteristic curve were 0.649, 0.734 and 0.656 (P < 0.05). There were significant differences in the cytokine expression levels of IL-17 and VEGF in different molecular typing (P values were 0.008 and 0.040, respectively). The expression levels of IL-17 and VEGF were higher in HER-2 receptor-positive and triple-negative patients than in hormone receptor-positive patients (P < 0.05). Also, no significant correlation was found between the various cytokines mentioned in the article and breast cancer lymph node metastasis and Tumor Node Metastasis stage (TNM stage). In addition, in the breast cancer surgery group, postoperative VEGF levels were lower (P < 0.05) and IL-6 levels were higher (P < 0.05) compared to preoperative levels.
Serum IL-6, IL-17, and VEGF are strongly associated with breast cancer development and can be used as a reference indicators for breast cancer diagnosis. In addition, post-operative VEGF levels decreases and IL-6 levels increases compared to pre-operative levels, which can also be used as an a postoperative follow-up indicator. In contrast, IL-5 and IL-8 have not found to be significantly associated with breast cancer patients in this study, which requires further study.
探讨乳腺癌患者外周血血管内皮生长因子(VEGF)、白细胞介素-5(IL-5)、白细胞介素-6(IL-6)、白细胞介素-8(IL-8)和白细胞介素-17(IL-17)浓度变化及其在乳腺癌分期和侵袭转移中的意义与临床价值。
选取2021年9月至2022年4月重庆医科大学附属第二医院的60例乳腺癌患者纳入乳腺癌手术组,同期选取30例乳腺良性疾病患者作为对照组。入院时及术后1周采集静脉血样本,检测血清中这些因子的表达。采用Wilcoxon检验和Spearman相关性分析等统计方法分析上述因子与患者临床病理特征的关系。
通过分析乳腺良恶性肿瘤患者的数据,发现血清IL-6、IL-17和VEGF水平存在关联。它们各自的操作特征曲线下面积分别为0.649、0.734和0.656(P<0.05)。不同分子分型中IL-17和VEGF的细胞因子表达水平存在显著差异(P值分别为0.008和0.040)。HER-2受体阳性和三阴性患者中IL-17和VEGF的表达水平高于激素受体阳性患者(P<0.05)。此外,本文提及的各种细胞因子与乳腺癌淋巴结转移及肿瘤-淋巴结-转移分期(TNM分期)之间未发现显著相关性。另外,在乳腺癌手术组中,术后VEGF水平降低(P<0.05),IL-6水平升高(P<0.05)。
血清IL-6、IL-17和VEGF与乳腺癌发生密切相关,可作为乳腺癌诊断的参考指标。此外,与术前相比,术后VEGF水平降低,IL-6水平升高,也可作为术后随访指标。相比之下,本研究未发现IL-5和IL-8与乳腺癌患者有显著关联,这需要进一步研究。